frutitsin | 4207-90-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 黄酮类化合物
• 英文名称: frutitsin
• 英文别名: Amorphigenin O-vicianoside；16,17-dimethoxy-6-[3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyprop-1-en-2-yl]-2,7,20-trioxapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one
• CAS: 4207-90-3
• 化学式: C₃₄H₄₀O₁₆
• 分子量: 704.682
• InChiKey: CMQOKNQYLSMKJC-SQVUTHPVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  50
• 可旋转键数：
  9
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  222
• 氢给体数：
  6
• 氢受体数：
  16

文献信息

• Verwendung von monosubstituierten selenorganischen Verbindungen zur Herstellung eines Arzneimittels sowie daraus hergestelltes Arzneimittel und Verfahren zu seiner Herstellung
  申请人：Birkmayer, Jörg, Prof.-Dr.

  公开号：EP0345247A2

  公开（公告）日：1989-12-06

  Verwendung des Selenmethionins zur Herstellung eines zur Behandlung des Parkinson-Syndroms, der M. Alzheimer oder anderer Formen präseniler Demenz geeigneten Arzneimittels.

  使用硒蛋氨酸制造适用于治疗帕金森综合症、阿尔茨海默病或其他形式的先兆性痴呆症的药物。
• Verwendung des Enzym-Cofaktors NADPH zur Herstellung eines Arzneimittels sowie daraus hergestelltes Arzneimittel und Verfahren zu seiner Herstellung
  申请人：Birkmayer, Jörg, Prof.-Dr.

  公开号：EP0345248A2

  公开（公告）日：1989-12-06

  Verwendung des Enzym-Cofaktors NADPH oder eines Salzes davon zur Herstellung eines zur Behandlung des Parkinson-Syndroms geeigneten Arzneimittels.

  使用酶辅助因子 NADPH 或其盐制造适用于治疗帕金森病的药物。
• COATING TOOL AND LIQUID MEDICINE COATING TOOL
  申请人：Nipro Corporation

  公开号：EP3524313A1

  公开（公告）日：2019-08-14

  An applicator includes: a liquid medicine container (130) having an opening (124), and a brush member (160) arranged adjacently to the liquid medicine container (130) to cover the opening (124). The brush member is made up of a plurality of fibers (140) that are bundled together. The brush member (160) has a tubular shape in a root portion located adjacently to the liquid medicine container (130), tapers from the root portion toward a top end portion located opposite to the liquid medicine container (130), and has a wedge shape in the top end portion,

  涂抹器包括：一个具有开口（124）的药液容器（130）和一个刷子部件（160），刷子部件紧靠药液容器（130）以覆盖开口（124）。刷子部件由捆绑在一起的多个纤维 (140) 组成。刷子部件 (160) 在靠近药液容器 (130) 的根部呈管状，从根部向与药液容器 (130) 相对的上端部分逐渐变细，在上端部分呈楔形、
• FORMULATIONS OF ACTIVE PRINCIPLES INCORPORATED IN SLNS SUITABLE FOR TRANSDERMAL ADMINISTRATION
  申请人：Gasco Maria Rosa

  公开号：US20100028432A1

  公开（公告）日：2010-02-04

  The present invention relates to formulations suitable for transdermal administration characterized by containing SLNs which contain active principles with a very short half-life and/or drugs with high activity.
• APPLICATOR AND LIQUID DRUG APPLICATOR
  申请人：NIPRO CORPORATION

  公开号：US20190247635A1

  公开（公告）日：2019-08-15

  An applicator includes: a liquid medicine container having an opening, and a brush member arranged adjacently to the liquid medicine container to cover the opening. The brush member is made up of a plurality of fibers that are bundled together. The brush member has a tubular shape in a root portion located adjacently to the liquid medicine container, tapers from the root portion toward a top end portion located opposite to the liquid medicine container, and has a wedge shape in the top end portion.